# Microglia–Neuron Crosstalk: An Intimate Molecular Conversation in Neurodegeneration

**Authors:** Shiqi Wang, Sichen Wang, Hongzhuan Chen, Jianrong Xu

PMC · DOI: 10.3390/ijms27042011 · International Journal of Molecular Sciences · 2026-02-20

## TL;DR

This paper explores how microglia, the brain's immune cells, communicate with neurons and influence neurodegenerative diseases.

## Contribution

The paper provides a comprehensive review of the molecular pathways of microglia–neuron interactions in health and disease.

## Key findings

- Microglia use direct and indirect pathways to communicate with neurons.
- Recent advances have revealed key molecules involved in microglia–neuron crosstalk.
- This crosstalk plays a role in both maintaining neuronal health and contributing to neurodegeneration.

## Abstract

Microglia are a unique cell population in the central nervous system (CNS) and serve as its resident immune cells. They have long been recognized for their critical contributions to CNS development and the maintenance of neuronal network health, particularly in the context of neuroprotection against neurodegenerative diseases. However, the mechanisms by which microglia interact with and influence neurons have remained largely unclear. Recent advances in genetics, pharmacology, and imaging technologies have begun to unveil the mechanisms underlying microglia–neuron communication. Here, from the perspective of microglia, we review the diverse direct and indirect pathways and key molecules through which microglia interact with neurons under both physiological and pathological conditions. This rapidly expanding knowledge is reshaping our understanding of neuron–glia physiology and pathology in neurodegenerative diseases.

## Full-text entities

- **Genes:** KCNJ9 (potassium inwardly rectifying channel subfamily J member 9) [NCBI Gene 3765] {aka GIRK3, KIR3.3}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, PDK2 (pyruvate dehydrogenase kinase 2) [NCBI Gene 5164] {aka PDHK2, PDKII}, C1qa (complement component 1, q subcomponent, alpha polypeptide) [NCBI Gene 12259] {aka Adic, C1q}, Htr1a (5-hydroxytryptamine (serotonin) receptor 1A) [NCBI Gene 15550] {aka Gpcr18}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, SNCA (synuclein alpha) [NCBI Gene 6622] {aka NACP, PARK1, PARK4, PD1}, OGA (O-GlcNAcase) [NCBI Gene 10724] {aka MEA5, MGEA5, NCOAT}, APOE (apolipoprotein E) [NCBI Gene 348] {aka AD2, APO-E, ApoE4, LDLCQ5, LPG}, Ncf1 (neutrophil cytosolic factor 1) [NCBI Gene 17969] {aka NCF-47K, NOXO2, Ncf-1, p47-phox, p47<phox>, p47phox}, GPNMB (glycoprotein nmb) [NCBI Gene 10457] {aka HGFIN, NMB, PLCA3}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, SIRT3 (sirtuin 3) [NCBI Gene 23410] {aka SIR2L3}, App (amyloid beta precursor protein) [NCBI Gene 11820] {aka Abeta, Abpp, Adap, Ag, Cvap, E030013M08Rik}, Stat3 (signal transducer and activator of transcription 3) [NCBI Gene 20848] {aka 1110034C02Rik, Aprf}, Itgam (integrin alpha M) [NCBI Gene 16409] {aka CD11b/CD18, CR3, CR3A, Cd11b, F730045J24Rik, Ly-40}, CX3CR1 (C-X3-C motif chemokine receptor 1) [NCBI Gene 1524] {aka CCRL1, CMKBRL1, CMKDR1, GPR13, GPRV28, V28}, TLR7 (toll like receptor 7) [NCBI Gene 51284] {aka IMD74, SLEB17, TLR7-like}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, HK2 (hexokinase 2) [NCBI Gene 3099] {aka HKII, HXK2}, HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}, IL6R (interleukin 6 receptor) [NCBI Gene 3570] {aka CD126, HIES5, IL-1Ra, IL-6R, IL-6R-1, IL-6RA}, P2RY12 (purinergic receptor P2Y12) [NCBI Gene 64805] {aka ADPG-R, BDPLT8, HORK3, P2T(AC), P2Y(12)R, P2Y(AC)}, IL33 (interleukin 33) [NCBI Gene 90865] {aka C9orf26, DVS27, IL1F11, NF-HEV, NFEHEV}, CNR2 (cannabinoid receptor 2) [NCBI Gene 1269] {aka CB-2, CB2, CX5}, Cx3cr1 (C-X3-C motif chemokine receptor 1) [NCBI Gene 13051] {aka mCX3CR1}, TREM2 (triggering receptor expressed on myeloid cells 2) [NCBI Gene 54209] {aka AD17, PLOSL2, TREM-2, Trem2a, Trem2b, Trem2c}, Drd3 (dopamine receptor D3) [NCBI Gene 13490] {aka D3R}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, Snca (synuclein, alpha) [NCBI Gene 20617] {aka NACP, alpha-Syn, alphaSYN}, Cd200 (CD200 molecule) [NCBI Gene 17470] {aka Mox2, OX2}, Cx3cl1 (C-X3-C motif chemokine ligand 1) [NCBI Gene 20312] {aka ABCD-3, CX3C, Cxc3, D8Bwg0439e, FK, Scyd1}, Cybb (cytochrome b-245, beta polypeptide) [NCBI Gene 13058] {aka CGD91-phox, Cgd, Cyd, Nox2, gp91-1, gp91phox}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, Pparg (peroxisome proliferator activated receptor gamma) [NCBI Gene 19016] {aka Nr1c3, PPAR-gamma, PPAR-gamma2, PPARgamma, PPARgamma2}, Il1a (interleukin 1 alpha) [NCBI Gene 16175] {aka Il-1a}, MIR95 (microRNA 95) [NCBI Gene 407052] {aka MIRN95, hsa-mir-95, miR-95}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, ENTPD1 (ectonucleoside triphosphate diphosphohydrolase 1) [NCBI Gene 953] {aka ATP-DPH, ATPDase, CD39, NTPDase-1, SPG64}, Cd47 (CD47 antigen (Rh-related antigen, integrin-associated signal transducer)) [NCBI Gene 16423] {aka 9130415E20Rik, B430305P08Rik, IAP, Itgp}, MFN2 (mitofusin 2) [NCBI Gene 9927] {aka CMT2A, CMT2A2, CMT2A2A, CMT2A2B, CPRP1, HMSN6A}, Trem2 (triggering receptor expressed on myeloid cells 2) [NCBI Gene 83433] {aka TREM-2, Trem2a, Trem2b, Trem2c}, Arrb2 (arrestin, beta 2) [NCBI Gene 216869] {aka Arr3}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, NT5E (5'-nucleotidase ecto) [NCBI Gene 4907] {aka CALJA, CD73, E5NT, NT, NT5, NTE}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, Dlg2 (discs large MAGUK scaffold protein 2) [NCBI Gene 23859] {aka A330103J02Rik, B230218P12Rik, B330007M19Rik, Dlgh2, Gm1197, Gm21505}, RIPK1 (receptor interacting serine/threonine kinase 1) [NCBI Gene 8737] {aka AIEFL, IMD57, RIP, RIP-1, RIP1}, SOCS2 (suppressor of cytokine signaling 2) [NCBI Gene 8835] {aka CIS2, Cish2, SOCS-2, SSI-2, SSI2, STATI2}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, ST2 (suppression of tumorigenicity 2) [NCBI Gene 6761], Il34 (interleukin 34) [NCBI Gene 76527] {aka 2010004A03Rik}, Camkk2 (calcium/calmodulin-dependent protein kinase kinase 2, beta) [NCBI Gene 207565] {aka 6330570N16Rik, mKIAA0787}, HEXB (hexosaminidase subunit beta) [NCBI Gene 3074] {aka ENC-1AS, HEL-248, HEL-S-111}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, Tmem119 (transmembrane protein 119) [NCBI Gene 231633] {aka obif}
- **Diseases:** dysfunction (MESH:D006331), stroke (MESH:D020521), amyloid (MESH:C000718787), learning deficits (MESH:D007859), diabetic peripheral neuropathy (MESH:D010523), EAE (MESH:D004681), depressive (MESH:D003866), neuropathic pain (MESH:D009437), degeneration (MESH:D009410), synaptic loss (MESH:D012183), hypoxia (MESH:D000860), amyloid plaques (MESH:D058225), cognitive and motor deficits (MESH:D003072), lipid-droplet-accumulating (MESH:D011017), spinal cord injury (MESH:D013119), Cerebral glucose hypometabolism (MESH:D018149), MS (MESH:D009103), neuronal dysfunction (MESH:D009461), major depressive disorder (MESH:D003865), ischemia (MESH:D007511), tMCAO (MESH:D020244), mitochondrial dysfunction (MESH:D028361), PD (MESH:D010300), pain (MESH:D010146), demyelination (MESH:D003711), lumbar disc degeneration (MESH:C535531), Inflammation (MESH:D007249), Neurodegenerative Diseases (MESH:D019636), DAM (MESH:D004194), injury to (MESH:D014947), neuronal atrophy (MESH:D001284), neuroinflammation (MESH:D000090862), Lewy bodies (MESH:D020961), lysosomal storage disorders (MESH:D016464), cancer (MESH:D009369), neurotoxic (MESH:D020258), AD (MESH:D000544), mitochondrial failure (MESH:D051437)
- **Chemicals:** iron (MESH:D007501), Lipid (MESH:D008055), LPS (MESH:D008070), MPTP (MESH:D015632), glutamine (MESH:D005973), Capsaicin (MESH:D002211), TUDCA (MESH:C031655), ATP (MESH:D000255), cordycepin (MESH:C058120), GM2 gangliosides (MESH:D005678), ROS (MESH:D017382), calcium (MESH:D002118), terazosin (MESH:C041226), NO (MESH:D009569), cholesterol (MESH:D002784), neuronal (MESH:C017835), serotonin (MESH:D012701), Glucose (MESH:D005947), glutamate (MESH:D018698), oleate (MESH:D019301), Dopamine (MESH:D004298), GABA (MESH:D005680), zinc (MESH:D015032), oxygen (MESH:D010100), potassium (MESH:D011188), bile acid (MESH:D001647), palmitate (MESH:D010168), adenosine (MESH:D000241), Ca2+ (-), superoxide (MESH:D013481), fatty acid (MESH:D005227), pentose phosphate (MESH:D010428), lipid hydroperoxides (MESH:D008054), TCA (MESH:D014233), FAD (MESH:D005182), cholesterol ester (MESH:D002788), ADP (MESH:D000244), L-lactate (MESH:D019344)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** rs4586

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940662/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940662/full.md

## References

181 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940662/full.md

---
Source: https://tomesphere.com/paper/PMC12940662